Home > Boards > US Listed > Biotechs > Geron Corp. (GERN)

Example of a Confidential Treatment Order

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Liquid_Bull Member Profile
 
Followed By 2
Posts 766
Boards Moderated 0
Alias Born 01/10/10
160x600 placeholder
Geron Reports Two Imetelstat Data Presentations at European Hematology Association Annual Congress GlobeNewswire Inc. - 6/17/2019 8:20:00 AM
Geron to Webcast KOL Event on June 25, 2019 GlobeNewswire Inc. - 6/10/2019 4:45:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 7:26:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 7:25:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 7:24:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 7:24:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 7:23:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 7:19:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2019 5:22:37 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/16/2019 9:26:22 AM
Geron Announces Two Presentations on Imetelstat at Upcoming European Hematology Association Annual Congress GlobeNewswire Inc. - 5/16/2019 9:05:49 AM
Geron Provides Imetelstat Program Update GlobeNewswire Inc. - 5/16/2019 8:00:00 AM
Geron Continues to Build Senior Leadership of Its Development Team GlobeNewswire Inc. - 5/16/2019 6:00:00 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 5/3/2019 2:33:55 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/2/2019 4:18:03 PM
Geron Corporation Reports First Quarter 2019 Financial Results GlobeNewswire Inc. - 5/2/2019 4:17:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/2/2019 4:09:48 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/22/2019 5:16:27 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/22/2019 5:11:37 PM
Geron Expands Senior Leadership of Its Development Team GlobeNewswire Inc. - 4/18/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/10/2019 7:46:59 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/8/2019 5:17:32 PM
Geron to Present at Needham Healthcare Conference GlobeNewswire Inc. - 4/2/2019 4:30:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/28/2019 8:31:56 AM
Geron Appoints Two New Independent Board Members GlobeNewswire Inc. - 3/28/2019 8:00:00 AM
Liquid_Bull   Saturday, 05/04/19 11:06:39 AM
Re: DrHarleyboy post# 6750
Post # of 6765 
Example of a Confidential Treatment Order
For example, a company may apply for a confidential treatment order by completing a confidential treatment request to keep information regarding a pricing arrangement made with a potential acquisition target secret. This request could be made on the basis that the company's competitors may use this information to go after the target with a more competitive price. Other common items kept confidential include milestone payments and other technical specifications.

I would love to see GERN get acquired at a nice premium but wouldn't the company that was acquiring GERN file the CTO?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist